+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Chemotherapy Market Report 2025 - Product Thumbnail Image

Chemotherapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Intestine Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Intestine Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Orphan Drugs Market 2024-2028 - Product Thumbnail Image

Orphan Drugs Market 2024-2028

  • Report
  • August 2024
  • 180 Pages
  • Global
From
From
Antibody Drug Conjugates Market Report 2025 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
From
From
From
STAT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Cosmetic Surgery Market Report 2025 - Product Thumbnail Image

Cosmetic Surgery Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
Loading Indicator